QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 18, Issue 6, 1992-2001, June 2007

This Article Full Text Full Text (PDF) All Versions of this Article: E06-09-0867v1 18/6/1992    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by L'honore, A. Articles by Fernandez, A. Search for Related Content PubMed PubMed Citation Articles by L'honore, A. Articles by Fernandez, A.

Identification of a New Hybrid Serum Response Factor and Myocyte Enhancer Factor 2-binding Element in MyoD Enhancer Required for MyoD Expression during Myogenesis

Cell Biology Unit, Institut de Génétique Humaine, Centre National de la Recherche Scientifique, 34396 Montpellier Cedex 05, France

Submitted September 27, 2006; Revised February 6, 2007; Accepted March 14, 2007
Monitoring Editor: J. Silvio Gutkind

MyoD is a critical myogenic factor induced rapidly upon activation of quiescent satellite cells, and required for their differentiation during muscle regeneration. One of the two enhancers of MyoD, the distal regulatory region, is essential for MyoD expression in postnatal muscle. This enhancer contains a functional divergent serum response factor (SRF)-binding CArG element required for MyoD expression during myoblast growth and muscle regeneration in vivo. Electrophoretic mobility shift assay, chromatin immunoprecipitation, and microinjection analyses show this element is a hybrid SRF- and MEF2 Binding (SMB) sequence where myocyte enhancer factor 2 (MEF2) complexes can compete out binding of SRF at the onset of differentiation. As cells differentiate into postmitotic myotubes, MyoD expression no longer requires SRF but instead MEF2 binding to this dual-specificity element. As such, the MyoD enhancer SMB element is the site for a molecular relay where MyoD expression is first initiated in activated satellite cells in an SRF-dependent manner and then increased and maintained by MEF2 binding in differentiated myotubes. Therefore, SMB is a DNA element with dual and stage-specific binding activity, which modulates the effects of regulatory proteins critical in controlling the balance between proliferation and differentiation.

* These authors contributed equally to this work.

Address correspondence to: Anne Fernandez (af{at}acrux.igh.cnrs.fr).

This article has been cited by other articles:

				Z. Yablonka-Reuveni, K. Day, A. Vine, and G. Shefer Defining the transcriptional signature of skeletal muscle stem cells J Anim Sci, April 1, 2008; 86(14_suppl): E207 - E216. [Abstract] [Full Text] [PDF]

				S. Camp, A. De Jaco, L. Zhang, M. Marquez, B. De La Torre, and P. Taylor Acetylcholinesterase Expression in Muscle Is Specifically Controlled by a Promoter-Selective Enhancesome in the First Intron J. Neurosci., March 5, 2008; 28(10): 2459 - 2470. [Abstract] [Full Text] [PDF]

				C. Angelelli, A. Magli, D. Ferrari, M. Ganassi, V. Matafora, F. Parise, G. Razzini, A. Bachi, S. Ferrari, and S. Molinari Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells Nucleic Acids Res., February 11, 2008; 36(3): 915 - 928. [Abstract] [Full Text] [PDF]

				S. Flanagin, J. D. Nelson, D. G. Castner, O. Denisenko, and K. Bomsztyk Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events Nucleic Acids Res., February 11, 2008; 36(3): e17 - e17. [Abstract] [Full Text] [PDF]